In this episode, Dr. Karen Torrejon (Founder and Chief Scientific Officer of Humonix Biosciences, Inc) shares with us how she turned her dissertation project in nanotechnology/tissue engineering into a thriving business even before her PhD defense, and how working with great people helped make her company a success. Having supportive mentors, and an admirable amount of persistence, helped Karen create the first ex vivo model of the primary outflow pathway of the eye, and expand her intellectual property outside of her alma mater. This tenacity, and the right team, eventually led to the creation of Humonix, a company whose mission it is to accelerate and de-risk drug development for their pharmacutical parthers.